Velge Bertrand 4/A
4/A · LifeMD, Inc. · Filed Sep 1, 2023
Insider Transaction Report
Form 4/AAmended
LifeMD, Inc.LFMD
Velge Bertrand
Director
Transactions
- Purchase
Common Stock
2023-06-07$2.19/sh+24,500$53,547→ 164,000 total(indirect: By LLC) - Purchase
Common Stock
2023-06-13$2.64/sh+49,465$130,375→ 213,465 total(indirect: By LLC)
Holdings
- 916,666(indirect: By Aliunde Ltd.)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.59 to $2.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.